These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1414289)

  • 1. Primary argon laser trabeculoplasty vs. pilocarpine. Short-term effects.
    Bergeå B; Svedbergh B
    Acta Ophthalmol (Copenh); 1992 Aug; 70(4):454-60. PubMed ID: 1414289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Glaucoma Laser Trial. I. Acute effects of argon laser trabeculoplasty on intraocular pressure. Glaucoma Laser Trial Research Group.
    Arch Ophthalmol; 1989 Aug; 107(8):1135-42. PubMed ID: 2667508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary argon laser trabeculoplasty vs pilocarpine. II: Long-term effects on intraocular pressure and facility of outflow. Study design and additional therapy.
    Bergeå B; Bodin L; Svedbergh B
    Acta Ophthalmol (Copenh); 1994 Apr; 72(2):145-54. PubMed ID: 8079617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of argon laser trabeculoplasty in primary open-angle and pseudoexfoliation glaucoma.
    Psilas K; Prevezas D; Petroutsos G; Kitsos G; Katsougiannopoulos V
    Ophthalmologica; 1989; 198(2):57-63. PubMed ID: 2710501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. The Glaucoma Laser Trial Research Group.
    Ophthalmology; 1990 Nov; 97(11):1403-13. PubMed ID: 2255512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser trabeculoplasty versus medication treatment as primary therapy for glaucoma.
    Tuulonen A; Koponen J; Alanko HI; Airaksinen PJ
    Acta Ophthalmol (Copenh); 1989 Jun; 67(3):275-80. PubMed ID: 2669435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of argon laser treatment of 100 eyes with open-angle glaucoma (trabeculoplasty, trabeculoretraction)].
    Moulin F; Haut J
    J Fr Ophtalmol; 1983; 6(8-9):661-70. PubMed ID: 6687151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular hypotensive effect of pilocarpine before and after argon laser trabeculoplasty.
    Teus MA; Castejón MA; Calvo MA; Fagúndez MA
    Acta Ophthalmol Scand; 1997 Oct; 75(5):503-6. PubMed ID: 9469544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary argon laser trabeculoplasty vs pilocarpine. III. Long-term effects on visual fields.
    Bergeå B; Bodin L; Svedbergh B
    Acta Ophthalmol Scand; 1995 Jun; 73(3):207-15. PubMed ID: 7493230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary argon laser trabeculoplasty vs pilocarpine. IV. Long-term effects on optic nerve head.
    Bergeå B; Bodin L; Svedbergh B
    Acta Ophthalmol Scand; 1995 Jun; 73(3):216-21. PubMed ID: 7493231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty--a controlled prospective clinical trial on 284 eyes].
    Best UP; Domack H; Schmidt V
    Klin Monbl Augenheilkd; 2007 Mar; 224(3):173-9. PubMed ID: 17385117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of diode laser trabeculoplasty for primary open-angle glaucoma and ocular hypertension.
    Moriarty AP; McHugh JD; Ffytche TJ; Marshall J; Hamilton AM
    Ophthalmology; 1993 Nov; 100(11):1614-8. PubMed ID: 8233384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty.
    Ren J; Shin DH; Chung HS; Birt CM; Glover BK; Juzych MS; Hughes BA; Kim C
    Ophthalmology; 1999 Jun; 106(6):1135-9. PubMed ID: 10366082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular pressure-lowering medications and long-term outcomes of selective laser trabeculoplasty.
    Woo DM; Healey PR; Graham SL; Goldberg I
    Clin Exp Ophthalmol; 2015; 43(4):320-7. PubMed ID: 25287743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Glaucoma Laser Trial (GLT): 6. Treatment group differences in visual field changes. Glaucoma Laser Trial Research Group.
    Am J Ophthalmol; 1995 Jul; 120(1):10-22. PubMed ID: 7611312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argon laser trabeculoplasty medical therapy to prevent the intraocular pressure rise associated with argon laser trabeculoplasty.
    Robin AL
    Ophthalmic Surg; 1991 Jan; 22(1):31-7. PubMed ID: 2014108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular pressure reduction after argon laser trabeculoplasty in open-angle glaucoma. A two-year follow-up.
    Bergeå B
    Acta Ophthalmol (Copenh); 1986 Aug; 64(4):401-6. PubMed ID: 3776504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilocarpine to prevent acute pressure increase following primary laser trabeculoplasty.
    Elsås T; Johnsen H; Stang O
    Eye (Lond); 1991; 5 ( Pt 4)():390-4. PubMed ID: 1743354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary therapy for chronic simple glaucoma the role of argon laser trabeculoplasty.
    Migdal C; Hitchings R
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 1)():62-6. PubMed ID: 3855338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary argon laser trabeculoplasty vs pilocarpine 2% in primary open angle glaucoma: two years follow-up study.
    Sharma A; Gupta A
    Indian J Ophthalmol; 1997 Jun; 45(2):109-13. PubMed ID: 9475029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.